0001387131-20-005869 Sample Contracts

COOPERATION AGREEMENT

Cooperation Agreement • June 22nd, 2020 • Glaxosmithkline PLC • Pharmaceutical preparations • New York

• Contract Type
  Cooperation Agreement
• Filed
  June 22nd, 2020
• Company
  Glaxosmithkline PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This COOPERATION AGREEMENT (this “Agreement”) is entered into as of June 22, 2020, by and among Theravance BIOPHARMA, Inc. (the “Company”), GlaxoSmithKline plc (“GSK”) and GSK FINANCE (NO.3) PLC (the “Issuer”).

REGISTRATION RIGHTS AGREEMENT

Registration Rights Agreement • June 22nd, 2020 • Glaxosmithkline PLC • Pharmaceutical preparations • New York

• Contract Type
  Registration Rights Agreement
• Filed
  June 22nd, 2020
• Company
  Glaxosmithkline PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 22, 2020, is by and among THERAVANCE BIOPHARMA, INC., a Cayman Islands exempted company (the “Company”), GLAXOSMITHKLINE PLC, a public limited company incorporated under the laws of England and Wales, with registered number 03888792 (“GSK”), and GSK FINANCE (NO.3) PLC, a public limited company incorporated under the laws of England and Wales, with registered number 12615561 (“GSK Issuer”).

WAIVER AND ASSIGNMENT OF REGISTRATION RIGHTS AND VOTING AGREEMENT

Registration Rights and Voting Agreement • June 22nd, 2020 • Glaxosmithkline PLC • Pharmaceutical preparations • Delaware

• Contract Type
  Registration Rights and Voting Agreement
• Filed
  June 22nd, 2020
• Company
  Glaxosmithkline PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This WAIVER AND ASSIGNMENT OF REGISTRATION RIGHTS AND VOTING AGREEMENT (this “Agreement”) is made and entered into as of June 22, 2020, by and among GSK Finance (No.3) plc, a public limited company incorporated under the laws of England and Wales (“GSK Finance”), Glaxo Group Limited (“GGL”) and Theravance Biopharma, Inc., a Cayman Islands exempted company (the “Company” and with GSK Finance and GGL, each a “Party”).

GSK Finance (No.3) plc

Indenture • June 22nd, 2020 • Glaxosmithkline PLC • Pharmaceutical preparations • New York

• Contract Type
  Indenture
• Filed
  June 22nd, 2020
• Company
  Glaxosmithkline PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS INDENTURE, dated as of June 22, 2020, is among GSK Finance (No.3) plc, a public limited company incorporated under the laws of England and Wales (the “Issuer”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as Guarantor (the “Guarantor”), and Deutsche Bank Trust Company Americas, as trustee (in such capacity, the “Trustee”), principal paying agent (in such capacity, the “Principal Paying Agent”), transfer agent (in such capacity, the “Transfer Agent”), principal exchange agent (in such capacity, the “Principal Exchange Agent”) and registrar (in such capacity, the “Registrar”).